If your child has asthma, treatment may involve a number of medications and devices made to transfer that medication into the airways. At some point, your child will need to learn how to properly use and care for his device.
Dr. Jen Kim, a member of the American Academy of Pediatrics, has great advice for parents of children with asthma.
Inhalers tend to be the treatment of choice for asthma, and there are a wide variety of brand names available. The first thing you should introduce into children’s treatment when they are on their own is the rescue inhaler. Its main purpose is to relax the muscles around airways temporarily in case they are tightened due to allergies, exposure to smoke, a cold, or physical exertion.
If your child’s symptoms tend to me more chronic or persistent, which Dr. Kim defines as more than twice a week on a regular basis, or waking up at least twice a week in the middle of the night due to symptoms, you may need more than a rescue inhaler. There are long-term, controlled medication options available, but asthma should be revisited every now and then since the degree of symptoms can fluctuate.
When Should Children Be Responsible for Inhaler Use?
Perhaps one of the biggest questions parents ask their pediatrician is “When do you turn treatment over from parent to child?” When your child has asthma, you become accustomed to monitoring treatments and storing the devices wherever needed throughout the house. But, what if they need to start using a device themselves?
Storage is one main concern. Dr. Kim suggests keeping the devices in a cool, dark place at room temperature. Options can vary greatly, and you may choose to store the inhaler in a backpack, your child’s pockets, or even give it to the teacher for safeguarding. It really can depend on your child’s age. Preschoolers and younger children need to be constantly assessed, and adult supervision should always be present to ensure kids are using their inhaler correctly and at the right times.
As a child grows older, maybe into the second decade of life, he or she may be able to discern when and where to use the inhaler. Every child is different, so it’s up to you to individually assess whether or not your child is ready to make those decisions. By the time they reach high school, most kids should know when to use their rescue inhaler.
If your child suffers from exercise-induced asthma, do not alter exercise, prohibit rigorous physical activity, or sit that activity out. It’s not acceptable in Dr. Kim’s opinion, since it could lead to an unhealthy, sedentary lifestyle and weight gain. Instead, have them exercise or play however they want, to the extent that they want, but have the rescue inhaler ready in case you need it.
Detection and Prevention
There is no surefire way to prevent asthma, and triggers can be different for everyone. Seasonal allergies may be a major trigger for some, while others have stable responses to allergies but smoke may be the trigger.
If you’re unsure of whether or not your child has asthma, look for the warning signs: wheezing is almost always associated with asthma, but, while it’s a major symptom, may not always be present. Coughing without a wheeze can also point to asthma, especially if kids are coughing every day or every night, or after exercise.
Dr. Kim recommends that children with asthma use their medications on a regular basis and that parents keep close contact with their child’s asthma specialist or pediatrician.
In the accompanying audio segment, Jen Kim, MD, discusses the proper use of an inhaler, proper storage of inhalers (not gym bags in the heat/sun or car glove compartments), when to consider changes to your child’s asthma treatment plan, and staying in touch with your pediatrician.
Asthma Treatments: Proper Ways to Keep Them Handy
Featuring:
Dr. Jen Kim joined NorthShore University HealthSystems in January 2014 and is on faculty at the University of Chicago Pritzker School of Medicine. She earned her MD from Northwestern University Feinberg School of Medicine, completed internship at St. Louis Children’s Hospital at Washington University i St. Louis, and finished residency in pediatrics at Children’s Memorial Hospital, where she also completed her fellowship in Allergy & Immunology. She stayed on as faculty at Children’s Memorial Lurie (Children's of Chicago) where she served as the division’s Clinical Practice Director for 5 years. In 2010, she moved to New York City to join the Icahn School of Medicine at Mount Sinai. During her four years as part of the Jaffe Food Allergy Institute, she published studies on the effect of dietary baked milk inclusion in children with milk allergy and served as clinical investigator of the first randomized double-blind, placebo-controlled study of the use of omalizumab in milk oral immunotherapy.
Dr. Kim is a member of the American Academy of Asthma, Allergy, and Immunology and American College of Asthma, Allergy, and Immunology and is a current committee member of the Section of Allergy & Immunology of the American Academy of Pediatrics. She serves as the assistant editor of the AAP Section of Allergy & Immunology Newsletter and provides input regarding allergy and immunology content on the www.healthychildren.org website.
Jen Kim, MD
Dr. Jen Kim joined NorthShore University HealthSystems in January 2014 and is on faculty at the University of Chicago Pritzker School of Medicine. She earned her MD from Northwestern University Feinberg School of Medicine, completed internship at St. Louis Children’s Hospital at Washington University i St. Louis, and finished residency in pediatrics at Children’s Memorial Hospital, where she also completed her fellowship in Allergy & Immunology. She stayed on as faculty at Children’s Memorial Lurie (Children's of Chicago) where she served as the division’s Clinical Practice Director for 5 years. In 2010, she moved to New York City to join the Icahn School of Medicine at Mount Sinai. During her four years as part of the Jaffe Food Allergy Institute, she published studies on the effect of dietary baked milk inclusion in children with milk allergy and served as clinical investigator of the first randomized double-blind, placebo-controlled study of the use of omalizumab in milk oral immunotherapy. Dr. Kim is a member of the American Academy of Asthma, Allergy, and Immunology and American College of Asthma, Allergy, and Immunology and is a current committee member of the Section of Allergy & Immunology of the American Academy of Pediatrics. She serves as the assistant editor of the AAP Section of Allergy & Immunology Newsletter and provides input regarding allergy and immunology content on the www.healthychildren.org website.